Walid Chemlali
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 3
- Cancer Genomics and Diagnostics 2
- Cancer-related molecular mechanisms research 2
- Oncology 7
- Cancer-related Molecular Pathways 3
- Co-authors
- Ivan Bièche (17 shared papers)Sophie Vacher (16 shared papers)Didier Meseure (7 shared papers)Céline Callens (6 shared papers)Rosette Lidereau (5 shared papers)Anne Schnitzler (10 shared papers)François Lallemand (4 shared papers)Nicolas ANDRE (4 shared papers)
- Journals
- Oncotarget (5 papers)British Journal of Cancer (3 papers)Molecular Cancer Research (2 papers)Cancers (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- FranceBelgiumSwitzerland
In The Last Decade
Walid Chemlali
25 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 77
- Cancer Research 338
- Oncology 279
- Otorhinolaryngology 42
- Biological Psychiatry 17
- Molecular Biology 464
Countries citing papers authored by Walid Chemlali
This map shows the geographic impact of Walid Chemlali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid Chemlali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid Chemlali more than expected).
Fields of papers citing papers by Walid Chemlali
This network shows the impact of papers produced by Walid Chemlali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid Chemlali. The network helps show where Walid Chemlali may publish in the future.
Co-authors
The 25 scholars most cited alongside Walid Chemlali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 101 | |
| 2 | 2016 | 85 | |
| 3 | 2018 | 81 | |
| 4 | 2016 | 80 | |
| 5 | 2018 | 77 | |
| 6 | 2019 | 74 | |
| 7 | 2018 | 52 | |
| 8 | 2019 | 50 | |
| 9 | 2015 | 49 | |
| 10 | 2020 | 46 | |
| 11 | 2016 | 41 | |
| 12 | 2018 | 38 | |
| 13 | 2019 | 35 | |
| 14 | 2019 | 30 | |
| 15 | 2017 | 29 | |
| 16 | 2016 | 29 | |
| 17 | 2019 | 25 | |
| 18 | 2018 | 24 | |
| 19 | 2018 | 22 | |
| 20 | 2016 | 19 |
About Walid Chemlali
Walid Chemlali is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Cancer-related Molecular Pathways (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer-related molecular mechanisms research (2 papers), Epigenetics and DNA Methylation (2 papers), Genetic factors in colorectal cancer (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Cancer Research (338 citations), Oncology (279 citations), Otorhinolaryngology (42 citations), Biological Psychiatry (17 citations) and Molecular Biology (464 citations). Walid Chemlali has collaborated with scholars based in France, Belgium and Switzerland. Frequent co-authors include Ivan Bièche, Sophie Vacher, Didier Meseure, Céline Callens, Rosette Lidereau, Anne Schnitzler, François Lallemand, Nicolas ANDRE, Kinan Drak Alsibai and Éric Pasmant. Their work appears in journals such as Oncotarget, British Journal of Cancer, Molecular Cancer Research, Cancers and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.